Spanios

Spanios is listed as a new startup research supplier in the Scientist.com network, with 1 site in 1 country.

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: New startup

3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
In Vitro Hydrogel-Based Culture of PDXs Enable the extended laboratory culture of cancer PDXs and other primary cells in 3D.

Human Organoids Test immuno-oncology drugs and therapies on fresh, unpropagated 3D tumor organoids to evaluate efficacy and understand drug mechanism of action. Understand the intact tumor immune microenvironment, cytotoxic efficacy...

Immunofocus™ Predict the response to anti PD1/PDL1 directed therapies.
In Vitro Efficacy Test Use in vitro models to test the efficacy of your products.

HuGEMM - Immuno-Oncology Model Evaluate human-specific therapeutics for checkpoint inhibitors, including anti-human PD-1, anti-human PDL-1, and anti-human CTLA-4 antibodies.
Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.

Fresh Functional Human Tissue Efficacy Assays Use fresh functional human tissue to assess pre-clinical efficacy of test compounds.
hTME-3DX Screen and Verify™ A sophisticated and physiologically relevant 3D model that recapitulates the patient tumor microenvironment.

CAR-T Efficacy In Vivo assessment of CAR-T and CAR-NK efficacy in a humanized mouse
Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.

Work with Spanios on Scientist.com

For prices, more details, or to contact Spanios, visit Scientist.com.